Safe Surgery Study for Glioblastoma Patients Comparing Awake Craniotomy and General Anesthesia Surgery
Led by Jasper Gerritsen · Updated on 2023-11-21
246
Participants Needed
5
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating surgical approaches for patients with Glioblastoma Multiforme GBM located in critical brain areas responsible for movement and language. This trial compares awake craniotomy, which uses direct brain stimulation during surgery to identify and protect vital functions, with traditional craniotomy performed under general anesthesia. GBM is a severe brain tumor with poor prognosis, and improving surgical safety and tumor removal could impact survival and quality of life.
Participants are randomly assigned to either awake craniotomy or surgery under general anesthesia with equal chance. In awake craniotomy, surgeons use electrical stimulation to map brain areas during surgery, working with neuropsychologists to monitor speech and movement. Surgery under general anesthesia is guided by neuronavigation without brain mapping. After surgery, only patients with confirmed GBM continue in the study and receive standard treatment including chemotherapy with Temozolomide and radiation therapy.
During the study, neurological function is assessed before surgery and at 6 weeks post-operation using the NIH Stroke Scale. Brain scans within 48 hours after surgery measure the amount of tumor removed. Quality of life is evaluated at multiple time points up to 6 months, and survival, tumor progression, and serious side effects are tracked for 12 months. The total study lasts 5 years, including patient recruitment over 4 years and 1 year of follow-up after surgery.
CONDITIONS
Brief Title
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
Research Team
J
Jasper Gerritsen, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Glioblastoma Multiforme diagnosed by MRI with characteristic ring-like contrast enhancement and tumor necrosis
Tumor located in or near critical brain areas controlling motor, sensory, or speech functions
Tumor deemed suitable for surgical removal by neurosurgeon
Karnofsky performance score of 80 or higher indicating good functional status
Ability to provide written informed consent
You will not qualify if you...
Tumors located in the cerebellum, brain stem, or midline areas
Multiple contrast-enhancing brain lesions
Presence of large non-contrast-enhancing tumor regions suggesting low grade glioma
Medical conditions preventing MRI use, such as having a pacemaker
Inability to provide consent or language barriers
History of psychiatric illness
Previous brain tumor surgery
Previous diagnosis of low-grade glioma
Another primary cancer diagnosed within past 5 years, except certain treated skin or in situ cancers
Severe speech impairments such as aphasia or dysphasia
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery
Duration - 1 day
Participants undergo either awake craniotomy with brain mapping or craniotomy under general anesthesia to remove the glioblastoma tumor.
1 surgical visit
Post-operative Follow-up
Duration - Up to 6 months
Participants are monitored for neurological outcomes, tumor resection success, and adverse events after surgery. Quality of life and neurological assessments are performed at multiple time points.
Follow-up visits at 6 weeks, 3 months, and 6 months post-surgery
Long-term Monitoring
Duration - Up to 12 months after surgery
Participants are followed for progression-free survival and overall survival with standard treatment and routine care.
Periodic assessments as per standard care
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Phase III Study of Oral Zotiraciclib for Recurrent Malignant Gliomas with IDH1 or IDH2 Mutations
Phase III Study of 18F-DOPA PETCT Imaging Optimization Using New Digital Scanner and Furosemide in Pediatric and Adult Patients with Neuroendocrine and Brain Tumors, Parkinsons, and Congenital Hyperinsulinism
Evaluation of 18F-Fluciclovine PET Imaging for Brain Metastasis Response After Stereotactic Radiosurgery
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Developing and Validating fMRI Software to Map Brain Function and Blood Flow Changes in Brain Tumor Surgery Patients
FRONTIER Study Evaluating Safety of TheraSphere GBM Device for Recurrent Glioblastoma
Phase 01 Study Evaluating BDTX-1535 Safety and CNS Penetration in High-Grade Glioma and Glioblastoma with EGFR Alterations Undergoing Tumor Resection
Open-Label Phase 1 Study of Oral GLIX1 for Adults with Recurrent or Progressive High-Grade Glioma
Phase 2 Study of Sitagliptin Treatment in Adults With Progressive Grade 4 Gliomas to Improve Immune Response
Phase 2 Randomized Study Comparing Ketogenic and Standard Anti-Cancer Diets in Adults With Newly Diagnosed Glioblastoma Receiving Standard Treatment
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The SAFE-trial: Safe surgery for glioblastoma multiforme: Awake craniotomy versus surgery under general anesthesia. Study protocol for a multicenter prospective randomized controlled trial.
Jasper K W Gerritsen, Markus Klimek, Clemens M F Dirven...
The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort study.
Jasper Kees Wim Gerritsen, Clemens Maria Franciscus Dirven, Steven De Vleeschouwer...
Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Jasper K W Gerritsen, Rosa H Zwarthoed, John L Kilgallon...